What treatments are available for cystic fibrosis? 

Cystic fibrosis is a lifelong genetic condition that requires a comprehensive and daily approach to management. While there is currently no cure, the landscape of treatment has transformed significantly in recent years, shifting from simply managing symptoms to addressing the underlying genetic cause. Modern care in the United Kingdom is delivered by specialist multidisciplinary teams who tailor a combination of advanced medications, physical therapies, and nutritional support to each individual. This proactive management aims to preserve lung function, support healthy growth, and improve the overall quality of life for those living with the condition. 

What We’ll Discuss in This Article 

• The revolutionary impact of CFTR modulator therapies. 

• Daily airway clearance techniques and chest physiotherapy. 

• Medications used to treat and prevent lung infections. 

• Nutritional management and the role of digestive enzymes. 

• Treatment for related complications like diabetes and liver disease. 

• Monitoring and specialist care within the NHS framework. 

Addressing the cause with CFTR modulators 

The most significant advancement in cystic fibrosis treatment is the development of CFTR modulator therapies, which target the faulty protein responsible for the condition. The NHS now provides access to several modulator drugs, including Kaftrio, Symkevi, Orkambi, and Kalydeco, which help the CFTR protein work more effectively at a cellular level. These medications are designed for specific genetic mutations, meaning eligibility depends on an individual’s unique genotype. For many, these drugs have led to a substantial increase in lung function and a reduction in the frequency of chest infections. 

As of 2025 and 2026, newer “triple-combination” therapies like Alyftrek (vanzacaftor, tezacaftor, and deutivacaftor) have been fast-tracked for use within the NHS. NICE guidance recommends Alyftrek as a once-daily alternative to existing treatments for patients aged six and over who have specific responsive mutations. These next-generation modulators are particularly beneficial because they offer a more convenient dosing schedule while maintaining or even improving the clinical outcomes seen with earlier versions of the medication. 

Respiratory treatments and airway clearance 

Keeping the lungs clear of thick, sticky mucus is a cornerstone of daily cystic fibrosis care. Airway clearance techniques (ACTs) are physical exercises and breathing patterns that help loosen and move secretions so they can be coughed out of the body. Physiotherapy for cystic fibrosis often includes the Active Cycle of Breathing Techniques (ACBT), autogenic drainage, and the use of positive expiratory pressure (PEP) devices to keep the airways open. Exercise is also highly encouraged as a natural way to support lung health and improve overall physical stamina. 

In addition to physical therapy, various inhaled medications are used to support the respiratory system. These include bronchodilators to open the airways and mucolytics, such as DNase (Pulmozyme) or hypertonic saline, which work to thin the mucus and make it easier to clear. Antibiotics are another essential tool, often used prophylactically as a daily inhaled or oral dose to prevent bacteria from colonising the lungs, or as a more intensive course if a “pulmonary exacerbation” or infection occurs. 

Digestive and nutritional management 

Because cystic fibrosis affects the pancreas, most individuals struggle to digest fats and proteins, requiring a specialized nutritional plan. Pancreatic Enzyme Replacement Therapy (PERT), commonly prescribed as Creon or Nutrizym, must be taken with every meal and snack that contains fat or protein. These enzymes replace the ones the pancreas cannot release, allowing the body to absorb the nutrients it needs for growth and energy. Weight gain and Body Mass Index (BMI) are closely monitored, and patients often follow a high-calorie, high-fat diet to compensate for malabsorption. 

Fat-soluble vitamins (A, D, E, and K) are also a critical part of the nutritional regime, as the body cannot absorb them easily from food alone. Supplementation is required to support bone health, vision, and the immune system. In some cases, if a patient is unable to maintain a healthy weight through diet and enzymes alone, the specialist team may recommend supplemental tube feeding (enteral nutrition) to provide extra calories overnight while the person sleeps. 

Managing related health complications 

Cystic fibrosis is a multi-system condition that can lead to secondary health issues, each requiring its own specific treatment approach. One common complication is cystic-fibrosis-related diabetes (CFRD), which occurs when the pancreas becomes scarred and produces less insulin. Unlike other forms of diabetes, CFRD is usually managed with insulin while maintaining the high-calorie diet necessary for the condition. Regular screening for blood sugar levels is a standard part of the annual review process for all adults and older children. 

Liver health is also monitored through regular blood tests and ultrasounds. If thick bile causes inflammation or scarring in the liver, medications such as ursodeoxycholic acid may be prescribed to help improve bile flow. For the sinuses, daily nasal rinses and steroid sprays are used to manage chronic sinusitis and prevent the growth of nasal polyps. Bone health is another priority, with DEXA scans used to check for early signs of osteoporosis, which can be managed with specific bone-strengthening medications and vitamin D. 

Monitoring and specialist services 

Care for cystic fibrosis in the UK is delivered through a network of specialist centres that provide access to a full multidisciplinary team. This team includes consultant doctors, specialist nurses, physiotherapists, dietitians, pharmacists, and clinical psychologists. Regular reviews are essential to track the progression of the condition and adjust the treatment plan. Since the widespread introduction of modulator therapies, many centres have moved toward a “hybrid” model of care, combining face-to-face clinic visits with remote monitoring of lung function and weight at home. 

Treatment Category	Common Examples	Primary Goal
Genetic	CFTR Modulators (Kaftrio, Alyftrek)	Correcting the faulty protein function.
Respiratory	Chest Physio, DNase, Antibiotics	Clearing mucus and preventing infection.
Nutritional	PERT (Creon), Vitamin A,D,E,K	Improving digestion and supporting growth.
Advanced	Lung Transplant	Replacing severely damaged organs.

Conclusion 

The range of treatments available for cystic fibrosis has expanded significantly, offering patients better control over their health than ever before. From daily airway clearance and nutritional enzymes to revolutionary genetic modulators, the focus of care is on preventing organ damage and supporting a high quality of life. Consistent adherence to a tailored treatment plan, developed with a specialist NHS team, is the most effective way to manage the condition long-term. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article provides an evidence-based overview of the current treatment landscape for cystic fibrosis, strictly following the clinical standards of the NHS and NICE. The content is produced by a professional medical writing team and has been reviewed by Dr. Rebecca Fernandez, a UK-trained physician with extensive experience in internal medicine, cardiology, and emergency care. It is intended to help patients and families understand the various therapies available and the standard of care provided within the United Kingdom.